Skip to main content

MoneyWorks4Me

Clarification sought from Sun Pharmaceutical Industries

07 Sep 2018 Evaluate

The Exchange has sought clarification from Sun Pharmaceutical Industries on September 07, 2018 with reference to news appeared on: www.moneycontrol.com dated September 07, 2018 quoting ‘Sun Pharma falls 5% on report of co getting 6 observations by US FDA for Halol unit’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1795.10
Dr. Reddys Labs. 1351.70
Cipla 1362.50
Lupin 2000.45
Zydus Lifesciences 1239.10
View more..